Is CKD-aP Hiding in Your Dialysis Center?
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
The Patient-Clinician Connection in Managing CKD-aP
Lucio Manenti, MD, PhD
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Potassium Binders in Practice: Clinical Trial Evidence
The Critical Interplay: CKD, HF, and Hyperkalemia
Javed Butler, MD
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Javed Butler, MD, MPH, MBA
Future Directions in Managing Hyperkalemia in CKD and HF
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
Raman Sankar, MD, PhD
Scott Aaronson, MD
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression